[Featured Stock] Three Billion Soars Over 20%... Surpasses 7,000 Won Intraday
The stock price of Three Billion, an AI-based genetic disease diagnostic testing company, is showing a strong gain of over 20%.
As of 2:12 PM on the 17th, just before the market close, Three Billion's stock is trading at 6,970 KRW per share, up 22.93% compared to the previous trading day. During the session, the price briefly surpassed 7,000 KRW per share.
This surge is attributed to the news that the company signed a memorandum of understanding (MOU) for genetic testing cooperation with Korea AstraZeneca before the market opened, which triggered buying interest.
Hot Picks Today
"Bought on Company Faith, Got 400% Return" Executive’s Account Swells to 15.9 Billion Won with 13 Billion Won Profit
- Will Stocks Jump First After the War?...Examining the Impact of the Strait of Hormuz Reopening [Weekend Money]
- Baek Kyunghoon: "Leaping Forward as a Full-Stack AI Supplier Nation... Korea to Take on Frontier Models" (Comprehensive)
- "Drinking Makes the Pain Disappear"... The 2,000-Won Value-for-Money 'Devil's Drink' [Delicious Stories]
- Samsung Quietly Prepared for 10 Years and Finally Did It... Surpasses US Giant to Become 'World No. 1'
Through this collaboration, Three Billion and AstraZeneca plan to establish a genetic testing system capable of completing diagnosis within two weeks for patients with atypical hemolytic uremic syndrome (aHUS), a rare disease.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.